<DOC>
	<DOCNO>NCT00492518</DOCNO>
	<brief_summary>Several study demonstrate significant reduction contrast-induced nephropathy ( CIN ; definition : increase serum creatinine &gt; =0.5mg/dl and/or &gt; =25 % increase within 48h contrast-medium ) acetylcysteine ( A ) theophylline ( T ) . However , result contradictory . Therefore , aim double-blind study compare effect A , T , combination A T ( A+T ) , placebo ( P ) .</brief_summary>
	<brief_title>Acetylcysteine , Theophylline , Combination Both Prophylaxis Contrast-Induced Nephropathy</brief_title>
	<detailed_description>Contrast-induced nephropathy ( CIN ) third leading cause hospital-acquired acute renal failure ( ARF ) . Accounting 12 % ARF case , CIN define increase serum creatinine least 0.5 mg/d ( “ Barrett´s definition ” ) and/or 25 % within 48 hour contrast-medium application . CIN associate prolonged hospitalisation increase mortality . CIN frequency depend several risk-factors include pre-existing renal dysfunction , high amount contrast-medium , diabetes , concurrent use nephrotoxic drug . CIN incidence low absence risk-factors ; however , high-risk patient , CIN occur 50 % patient . A variety prophylactic approach investigate . Despite nephro-protective effect hydration saline sodium bicarbonate , trial report CIN-incidences 20 50 % despite hydration . Several study two recent meta-analyses demonstrate significant reduction renal impairment contrast-medium use medical prophylaxis adenosine antagonist theophylline . However , recent trial fail prove prophylactic effect theophylline . The antioxidant acetylcysteine ( ACC ) effective patient impair renal function least six study , preventive least 21 trial two recent meta-analyses . A recent study compare prophylactic efficacy theophylline acetylcysteine demonstrate superior prophylactic effect theophylline . Nevertheless , study include placebo group , restrict patient impaired renal function exclusively enrol ICU-patients . Therefore , perform double-blinded study compare effect acetylcysteine , theophylline , combination , placebo patient impaired renal function ( serum creatinine &gt; =1.3mg/dl ) parenterally receive &gt; =100ml contrast-medium .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<mesh_term>Theophylline</mesh_term>
	<criteria>Impaired renal function ( serum creatinine &gt; =1.3mg/dl ) &gt; =100ml contrastmedium Age &gt; = 18years Informed consent Previous dialysis and/or haemofiltration Pretreatment acetylcysteine and/or theophylline within last 2 day , Pregnancy Contraindications theophylline ( untreated high grade arrhythmia history seizure ) acetylcysteine ( know allergy ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>Contrast Induced Nephropathy</keyword>
	<keyword>Prophylaxis</keyword>
	<keyword>Theophylline</keyword>
	<keyword>Acetylcysteine</keyword>
	<keyword>Coronary angiography</keyword>
</DOC>